Presented positive interim data through 52 weeks and beyond for 4D-150 in wet AMD from PRISM Phase 1/2 clinical trial highlighting robust and durable clinical activity across diverse patient populatio ...

Andrew King digs into the background of the Snellen visual acuity chart, perhaps the object most associated with optometry in ...

Glaukos reported robust fourth-quarter revenues, but shares plunged 24.8% post-earnings. Can expanding iDose TR adoption and ...

Regulatory News: ABIONYX Pharma, (FR0012616852 - ABNX - eligible for PEA PME), a next generation biopharma company dedicated ...

A single injection of a healthy gene allowed blind children to recognize objects, shapes, and even read — offering hope for ...

Researchers from London's Moorfields Eye Hospital, biotech firm MeiraGTx and University College London have demonstrated that ...

Patients who underwent bilateral treatment experienced a higher rate of clinically relevant recovery, the authors reported.

Imagine a non-invasive, low-risk and cutting-edge therapy that can protect the vision of older adults. For the millions of ...

Market OverviewThe Global Ophthalmic Devices Market is experiencing robust growth due to increasing prevalence of eye ...

Prayagraj: The ash-smeared Naga Sadhus are revered as the torch bearers of Sanatan Dharma and share a vision for spiritual enlightenment.

What’s behind the shocking rise in myopia and how did we find ourselves walking blindfolded into a catastrophic loss of sight?

Vuity offers a promising new approach to managing the effects of presbyopia, providing a convenient alternative for those looking to reduce their reliance on reading glasses. While not a cure, Vuity ...